[시장보고서]경카테터 색전 및 폐색 기기 시장 : 제품별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

경카테터 색전 및 폐색 기기 시장 : 제품별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Transcatheter Embolization and Occlusion Devices Market, By Product, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

상품코드 : 1836311

리서치사 : AnalystView Market Insights

발행일 : 2025년 09월

페이지 정보 : 영문 303 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,684,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,702,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,143,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

경카테터 색전 및 폐색 기기 시장 규모는 2024년 54억 9,320만 달러로 2025년부터 2032년까지 CAGR 7.80%로 성장할 것으로 예상됩니다.

경카테터 색전 및 폐색 기기는 카테터를 사용하면서 특정 신체 부위를 통해 합성 색전물을 체내에 삽입하거나 통과시킬 수 있습니다. 경카테터 색전술은 중재적 방사선 치료에서 암 종양으로 가는 혈류를 차단하기 위해 사용되는 최소침습적 기술입니다. 종양을 표적으로 하는 많은 전략을 밝히기 위해 혈액 공급 차단과 세포 독성을 동시에 수행하는 화학요법 약물의 코팅에 합성 물질이 사용되기도 합니다.

경카테터 색전 및 폐색 기기 시장 - 시장 역학

최소침습적 기술에 대한 수요 증가로 시장 성장 촉진

최소침습적 기술에 대한 수요 증가는 가까운 장래에 경카테터 색전 및 폐색 기기 시장의 성장을 촉진할 것으로 예상됩니다. 최소침습수술은 작은 절개나 자연스러운 신체 개구부를 이용해 내부 구조, 장기, 조직에 접근하여 치료하는 것으로 환자의 신체에 가해지는 외상을 줄여줍니다. 경카테터 색전 및 폐색 장치는 이러한 기술에서 중요한 역할을 하며, 침습성 감소, 회복 시간 단축, 표적 치료, 통증 감소, 합병증 위험 감소, 외래 수술 가능성 등 여러 가지 이점을 제공합니다. 예를 들어, 최소침습 의료 제품을 전문으로 하는 미국 기술 기업 Intuitive Surgical Inc.는 2022년에 다빈치 수술 시스템을 사용하여 약 187만 5,000건의 수술이 이루어질 것이며, 이는 2021년 약 159만 4,000건보다 18% 증가한 수치라고 보고했습니다. 그 결과, 최소침습적 기술에 대한 수요 증가는 경카테터 색전 및 폐색 기기 시장의 주요 촉진요인으로 작용하고 있습니다.

경카테터 색전 및 폐색 기기 시장 - 세분화 분석:

세계 경카테터 색전 및 폐색 기기 시장은 제품 및 지역을 기준으로 세분화됩니다.

시장은 코일과 비코일의 두 가지 제품 기반 카테고리로 구성됩니다. 비코일 부문은 다양한 임상적 응용 분야에서 다재다능하고 효과적이기 때문에 2025년에 가장 높은 매출 점유율을 차지했습니다. 액체 색전제 및 입자 색전 제품과 같은 비코일 장치는 정확하고 제어된 색전술을 제공하여 복잡한 혈관 상태를 치료하는 데 이상적입니다. 까다로운 해부학적 구조에 대응하고 합병증을 최소화하면서 우수한 결과를 얻을 수 있는 능력은 중재적 방사선 전문의와 외과 의사들 사이에서 높은 평가를 받고 있습니다. 이러한 선호도 증가는 이 부문의 시장 우위에 기여하고 있습니다.

경카테터 색전 및 폐색 기기 시장 - 지리적 인사이트

북미 경카테터 색전 및 폐색 기기 시장은 2025년 세계 시장을 장악했습니다. 이는 중재적 방사선(IR) 시술의 사용 증가에 따른 것입니다. 최소침습적 IR 시술인 자궁근종 색전술(UFE)은 증상이 있는 자궁근종의 치료 옵션으로 인기가 높아지고 있습니다. 이 비수술적 접근법은 회복 속도를 높이고 자궁 적출의 필요성을 줄여줍니다. 덜 침습적인 치료에 대한 환자들의 수요 증가와 의료진들의 인식이 높아지면서 색전술 장비의 사용이 증가하고 있으며, 이러한 혁신적인 솔루션의 시장이 확대되고 있습니다. 이 장비는 심방세동과 정맥류 치료에 사용됩니다.

아시아태평양의 경카테터 색전 및 폐색 장치 시장은 2025년부터 2032년까지 가장 빠르게 성장할 것으로 예상됩니다. 이 지역의 암 유병률 증가로 인해 이러한 장비에 대한 수요가 증가하고 있습니다. 색전술이 종양 관리의 중요한 부분인 간암, 폐암 등 다양한 암에 효과적인 치료 옵션을 제공합니다. 의료 투자 증가는 첨단 의료 기술에 대한 접근성을 높이고 의료 인프라를 개선함으로써 시장 성장을 촉진하고 있습니다. 암 발병률의 증가와 헬스케어 역량 확대가 맞물리면서 경카테터 색전 및 폐색 기기 산업은 지역 전체에서 발전할 것으로 예상됩니다.

경카테터 색전 및 폐색 장치 시장 - 경쟁 상황:

경카테터 색전 및 폐색 장치 시장은 경쟁이 치열하며, Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, DePuy Synthes(Johnson & Johnson) 등이 시장을 주도하고 있습니다. 이 회사들은 색전 코일, 혈관 플러그, 액체 색전제 등 다양한 혁신적 장치를 제공하고 있으며, 첨단 영상 진단 시스템 및 카테터 내비게이션 시스템과 자주 통합되고 있습니다. 경쟁은 기술 혁신, 소형화, 종양학, 신경학, 말초혈관 시술의 안전성 및 유효성 향상을 중심으로 전개되고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제9장 주요 벤더 분석 - 경카테터 색전 및 폐색 기기 업계

경쟁 벤치마킹
- Competitive Dashboard
- Competitive Positioning
기업 개요
- Abbott
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic
- DePuy Synthes(Johnson & Johnson)
- Stryker
- Cordis
- Pfizer Inc.
- Sirtex SIR-Spheres Pty Ltd.
- Nordion(Canada) Inc.
- 기타

제10장 애널리스트의 전방위적 전망

KSM

영문 목차

영문목차

Transcatheter Embolization and Occlusion Devices Market size was valued at US$ 5,493.20 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.

Transcatheter embolization and occlusion devices enable the insertion or passage of a synthetic embolus into the body via a specific body part while utilizing a catheter. Transcatheter embolization is a minimally invasive technique used in interventional radiology to stop blood flow to cancerous tumors. To identify many strategies for targeting tumors, synthetic materials are occasionally used to coat chemotherapeutic medications in order to perform simultaneous acts of blood supply blocking and cytotoxicity.

Transcatheter Embolization and Occlusion Devices Market- Market Dynamics

Increasing demand for minimally invasive techniques fuels market growth.

The growing demand for minimally invasive techniques is expected to drive the growth of the transcatheter embolization and occlusion device market in the near future. Minimally invasive surgeries use small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. Transcatheter embolization and occlusion devices play an important role in these techniques, providing numerous benefits such as reduced invasiveness, shorter recovery times, targeted treatment, less pain, lower complication risks, and the possibility of outpatient procedures. For instance, Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive medical products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, up 18% from about 1,594,000 in 2021. As a result, the growing demand for minimally invasive techniques is a major driver in the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2025-2032)

Based on Product segmentation, non-coil was predicted to show maximum market share in the year 2024

On the basis of region, North American was the leading revenue generator in 2024

Transcatheter Embolisation and Occlusion Devices Market- Segmentation Analysis:

The Global Transcatheter Embolisation and Occlusion Devices Market is segmented on the basis of Product and Region.

Two product-based categories comprise the market: Coil and Non-Coil. The non-coil segment will dominate the market with the highest revenue share in 2025, owing to its versatility and effectiveness in a variety of clinical applications. Non-coil devices, such as liquid embolic agents and particle embolization products, provide precise and controlled embolization, which is ideal for treating complex vascular conditions. Their ability to navigate difficult anatomy and provide superior results with minimal complications has earned them high praise among interventional radiologists and surgeons. This growing preference has contributed to the segment's market dominance.

Transcatheter Embolization and Occlusion Devices Market- Geographical Insights

The North American transcatheter embolization and occlusion device market will dominate the global market in 2025. This is due to the increased use of interventional radiology (IR) procedures. Uterine Fibroid Embolization (UFE), a minimally invasive IR procedure, is increasingly popular as a treatment option for symptomatic uterine fibroids. This nonsurgical approach allows for faster recovery and reduces the need for hysterectomy. Rising patient demand for less invasive treatments, combined with increased awareness among healthcare providers, is driving up the use of embolization devices and expanding the market for these innovative solutions. These devices are used to treat atrial fibrillation and varicose veins.

The Asia Pacific transcatheter embolization and occlusion device market is expected to grow the fastest between 2025 and 2032. The growing prevalence of cancer in the region is driving up demand for these devices. They provide effective treatment options for a variety of cancers, including liver and lung cancer, where embolization is an important part of tumor management. Rising healthcare investments are fueling market growth by increasing access to advanced medical technologies and improving healthcare infrastructure. This combination of rising cancer rates and expanding healthcare capabilities is expected to propel the transcatheter embolization and occlusion devices industry forward across the region.

Transcatheter Embolization and Occlusion Devices Market- Competitive Landscape:

The Transcatheter Embolization and Occlusion Devices Market is highly competitive, with Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, and DePuy Synthes (Johnson & Johnson) leading the way. These companies provide a diverse range of innovative devices, such as embolization coils, vascular plugs, and liquid embolic agents, which are frequently integrated with advanced imaging and catheter navigation systems. The competition revolves around technological innovation, miniaturization, and increased safety and efficacy for oncology, neurology, and peripheral vascular procedures.

Recent Developments:

In January 2025, Stryker has agreed to acquire Inari Medical for USD 4.9 billion, expanding its presence in venous thromboembolism care.

In July 2025, Teleflex acquired BIOTRONIK's vascular intervention business for EUR 760 million, expanding its portfolio to include drug-coated balloons and the Freesolve resorbable scaffold.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott
Boston Scientific Corporation
Terumo Corporation
Medtronic
DePuy Synthes (Johnson & Johnson)
Stryker
Cordis
Pfizer Inc.
Sirtex SIR-Spheres Pty Ltd.
Nordion (Canada) Inc.
Others

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Coil
Pushable Coils
Detachable Coils
Non Coil
Flow Diverting Devices
Embolization Particles
Liquid Embolics
Other Embolization and Occlusion Devices
Accessories

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Transcatheter Embolization And Occlusion Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Transcatheter Embolization And Occlusion Devices Market Snippet by Product
- 2.1.2. Transcatheter Embolization And Occlusion Devices Market Snippet by Country
- 2.1.3. Transcatheter Embolization And Occlusion Devices Market Snippet by Region
2.2. Competitive Insights

3. Transcatheter Embolization And Occlusion Devices Key Market Trends

3.1. Transcatheter Embolization And Occlusion Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Transcatheter Embolization And Occlusion Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Transcatheter Embolization And Occlusion Devices Market Opportunities
3.4. Transcatheter Embolization And Occlusion Devices Market Future Trends

4. Transcatheter Embolization And Occlusion Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Transcatheter Embolization And Occlusion Devices Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Transcatheter Embolization And Occlusion Devices Market Landscape

6.1. Transcatheter Embolization And Occlusion Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Transcatheter Embolization And Occlusion Devices Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Coil
  - 7.1.2.1. Pushable Coils
  - 7.1.2.2. Detachable Coils
- 7.1.3. Non Coil
  - 7.1.3.1. Flow Diverting Devices
  - 7.1.3.2. Embolization Particles
  - 7.1.3.3. Liquid Embolics
  - 7.1.3.4. Other Embolization and Occlusion Devices
  - 7.1.3.5. Accessories

8. Transcatheter Embolization And Occlusion Devices Market- By Geography

8.1. Introduction
- 8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
8.2. North America
- 8.2.1. Overview
- 8.2.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in North America
- 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.2.5. U.S.
  - 8.2.5.1. Overview
  - 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.2.6. Canada
  - 8.2.6.1. Overview
  - 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3. Europe
- 8.3.1. Overview
- 8.3.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Europe
- 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.5. Germany
  - 8.3.5.1. Overview
  - 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.6. UK
  - 8.3.6.1. Overview
  - 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.7. France
  - 8.3.7.1. Overview
  - 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.8. Italy
  - 8.3.8.1. Overview
  - 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.9. Spain
  - 8.3.9.1. Overview
  - 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.10. The Netherlands
  - 8.3.10.1. Overview
  - 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.11. Sweden
  - 8.3.11.1. Overview
  - 8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.12. Russia
  - 8.3.12.1. Overview
  - 8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.13. Poland
  - 8.3.13.1. Overview
  - 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.14. Rest of Europe
  - 8.3.14.1. Overview
  - 8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
- 8.4.1. Overview
- 8.4.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Asia Pacific
- 8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.5. China
  - 8.4.5.1. Overview
  - 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.6. India
  - 8.4.6.1. Overview
  - 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.7. Japan
  - 8.4.7.1. Overview
  - 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.8. South Korea
  - 8.4.8.1. Overview
  - 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.9. Australia
  - 8.4.9.1. Overview
  - 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.10. Indonesia
  - 8.4.10.1. Overview
  - 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.11. Thailand
  - 8.4.11.1. Overview
  - 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.12. Philippines
  - 8.4.12.1. Overview
  - 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.13. Rest of APAC
  - 8.4.13.1. Overview
  - 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5. Latin America (LATAM)
- 8.5.1. Overview
- 8.5.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Latin America
- 8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.5. Brazil
  - 8.5.5.1. Overview
  - 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.6. Mexico
  - 8.5.6.1. Overview
  - 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.7. Argentina
  - 8.5.7.1. Overview
  - 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.8. Colombia
  - 8.5.8.1. Overview
  - 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.9. Rest of LATAM
  - 8.5.9.1. Overview
  - 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa (MEA)
- 8.6.1. Overview
- 8.6.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Middle East and Africa
- 8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.5. Saudi Arabia
  - 8.6.5.1. Overview
  - 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.6. UAE
  - 8.6.6.1. Overview
  - 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.7. Israel
  - 8.6.7.1. Overview
  - 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.8. Turkey
  - 8.6.8.1. Overview
  - 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.9. Algeria
  - 8.6.9.1. Overview
  - 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.10. Egypt
  - 8.6.10.1. Overview
  - 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.11. Rest of MEA
  - 8.6.11.1. Overview
  - 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Transcatheter Embolization And Occlusion Devices Industry

9.1. Competitive Benchmarking
- 9.1.1. Competitive Dashboard
- 9.1.2. Competitive Positioning
9.2. Company Profiles
- 9.2.1. Abbott
- 9.2.2. Boston Scientific Corporation
- 9.2.3. Terumo Corporation
- 9.2.4. Medtronic
- 9.2.5. DePuy Synthes (Johnson & Johnson)
- 9.2.6. Stryker
- 9.2.7. Cordis
- 9.2.8. Pfizer Inc.
- 9.2.9. Sirtex SIR-Spheres Pty Ltd.
- 9.2.10. Nordion (Canada) Inc.
- 9.2.11. Others

10. 360 Degree AnalystView

11. Appendix

11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us